Commentary: Why Metallic Stents Remain the Worst Type of Endovascular Device,Except for All the Others

Abstract

Keywords

bioresorbable vascular scaffold endovascular therapy infrapopliteal arteries peripheral artery disease stent

Get full access to this article

View all access options for this article.

References

Tan

Schatz

RA.

The history of coronary stenting. Interv Cardiol Clin. 2016;5:271–280.

Torrado

Buckley

Durán

et al . Restenosis, stent thrombosis, and bleeding complications: navigating between Scylla and Charybdis. J Am Coll Cardiol. 2018;71:1676–1695.

Giordano

Musumeci

D’Angelillo

et al . Effects of glycoprotein IIb/IIIa antagonists: antiplatelet aggregation and beyond. Curr Drug Metab. 2016;17:194–203.

Palmerini

Biondi-Zoccai

Della Riva

et al . Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2014;63:299–307.

Capodanno

Bioresorbable scaffolds in coronary intervention: unmet needs and evolution. Korean Circ J. 2018;48:24–35.

Bangalore

Bezerra

Rizik

et al . The state of the Absorb bioresorbable scaffold: consensus from an expert panel. JACC Cardiovasc Interv. 2017;10:2349–2359.

Regazzoli

Leone

Colombo

et al . New generation bioresorbable scaffold technologies: an update on novel devices and clinical results. J Thorac Dis. 2017;9(suppl 9):S979–S985.

Ellis

Kereiakes

Metzger

et al.;

ABSORB III Investigators. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med. 2015;373:1905–1915.

Mahmoud

Barakat

Elgendy

et al . Long-term efficacy and safety of everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomized trials. Circ Cardiovasc Interv. 2017;10:e005286.

10.

Varcoe

Schouten

Thomas

et al . Initial experience with the absorb bioresorbable vascular scaffold below the knee: six-month clinical and imaging outcomes. J Endovasc Ther. 2015;22:226–232.

11.

Varcoe

Schouten

Thomas

et al . Experience with the Absorb everolimus-eluting bioresorbable vascular scaffold in arteries below the knee: 12-month clinical and imaging outcomes. JACC Cardiovasc Interv. 2016;9:1721–1728.

12.

Varcoe

Thomas

Lennox

AF.

Three-year results of the Absorb everolimus-eluting bioresorbable vascular scaffold in infrapopliteal arteries. J Endovasc Ther. 2018;25:694–701.

13.

DeRubertis

Kum

Varcoe

RL.

Editorial: The demise of the Absorb BVS: lessons learned from the discontinuation of a disappearing stent. J Endovasc Ther. 2018;25:706–709.

14.

Varcoe

Thomas

Rapoza

et al . Lessons learned regarding handling and deployment of the Absorb Bioresorbable Vascular Scaffold in infrapopliteal arteries. J Endovasc Ther. 2017;24:337–341.

15.

Giordano

Messina

Biondi-Zoccai

Successful treatment of a subclavian artery stenosis with a coronary bioresorbable vascular scaffold. J Endovasc Ther. 2016;23:653–656.

16.

Giordano

Ferraro

Corcione

et al . Endovascular therapy for infrainguinal artery disease with coronary devices: a retrospective observational study comparing drug-eluting stents versus bioresorbable vascular scaffolds. Angiology. 2017;68:59–66.

17.

Giordano

Ferraro

Corcione

et al . Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report. Int J Surg Case Rep. 2016;21:78–82.

18.

Onuma

Serruys

Perkins

et al . Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bio-resorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human. Circulation. 2010;122:2288–2300.

19.

Dake

Ansel

Jaff

et al ; Zilver PTX Investigators. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016;133:1472–1483.

20.

Braden

Xenopoulos

Young

et al . Transluminal extraction catheter atherectomy followed by immediate stenting in treatment of saphenous vein grafts. J Am Coll Cardiol. 1997;30:657–663.